论文部分内容阅读
目的探讨经导管动脉灌注与栓塞化疗治疗原发性肝癌的疗效。方法经股动脉穿刺至肝固有动脉或肝总动脉。Ａ组：经导管注入抗癌药物后拔管。Ｂ组：连接注药盒，经注药盒反复给药。Ｃ组：经导管注入碘油与抗癌药混悬剂栓塞化疗，然后拔管。结果总有效率Ａ、Ｂ、Ｃ三组分别为５０％、６７．８％、和８３．３％。生存期Ａ、Ｂ、Ｃ分别为６．２月、６．４月和４．８月。最长的一例已存活１５个月，病灶基本消失。结论结果表明三种方法均安全有效。栓塞化疗的效果高于单纯动脉灌注化疗，栓塞化疗是治疗肝癌的较好的非手术疗法。
Objective To investigate the efficacy of transcatheter arterial infusion and embolization chemotherapy for primary liver cancer. Methods The femoral artery was punctured into the proper hepatic artery or common hepatic artery. Group A: Extubation after catheter infusion of anticancer drugs. Group B: Connect the injection kit and repeat the administration via the injection kit. Group C: Infusion of lipiodol and anticancer drug suspension embolization chemotherapy, and then extubation. Results The total effective rates of A, B, and C groups were 50%, 67.8%, and 83.3%, respectively. Lifetimes A, B, and C were 6.2 months, 6.4 months, and 4.8 months, respectively. The longest case has survived for 15 months and the lesions have basically disappeared. Conclusion The results show that all three methods are safe and effective. The effect of embolization chemotherapy is higher than that of arterial infusion chemotherapy alone. Embolization chemotherapy is a better non-surgical treatment for liver cancer.